Company Overview
- Headquarters
- 930 Winter Street, Suite M-500, Waltham MA
- Website
- aerovatetx.com
- Phone
- (617) 443-2400
- Employees
- 33
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is Aerovate Therapeutics Inc
Aerovate Therapeutics Inc. is a clinical stage biopharmaceutical company based in Waltham, Massachusetts. The company employs 33 people and operates in the United States. Aerovate Therapeutics specializes in developing drugs aimed at improving the lives of patients suffering from rare cardiopulmonary diseases. Their primary focus is on AV-101, a dry powder inhaled formulation of imatinib, intended for the treatment of pulmonary arterial hypertension (PAH). Aerovate distinguishes itself through its dedication to developing innovative therapies for underserved patient populations with rare cardiopulmonary diseases. Their commitment to advancing AV-101 demonstrates their focus on providing meaningful improvements in patient outcomes. For more information about Aerovate Therapeutics Inc. and its groundbreaking therapies, please visit their website at aerovatetx.com.
Company Leadership
Aerovate Therapeutics Inc Industry Tags
Companies Similar to Aerovate Therapeutics Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Aerovate Therapeutics Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |